Shanxi Hetai Biomedical Capital Management, based in Xi'an, is founded in February 2012. The firm is a private equity firm targeting growth opportunities in the Chinese market, including biotechnology, biomedical, agriculture, technology, internet, information services and healthcare.
Growth
2 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.